
425.83MUSD

See which Billionaires own this investment
Type
Common Stock
Exchange
NASDAQ
Currency Code
USD
Currency Name
US Dollar
Country Name
USA
Country ISO
US
ISIN
US05280R1005
CUSIP
05280R100
Sector
Healthcare
Industry
Biotechnology
Fiscal Year End
December
IPO date
-
Updated At
-
PE Ratio
-
PEG Ratio
-
Book Value
5.91
Dividend Share
-
Dividend Yield
-
Earnings Share
-1.08
Wall Street Target Price
8.68
EPS Estimate Current Year
-0.96
EPS Estimate Next Year
-0.71
EPS Estimate Current Quarter
-0.4323
EPS Estimate Next Quarter
-0.255
Most Recent Quarter
-
Revenue TTM
1,078,500
Gross Profit TTM
-26,476,000
EBITDA
-68,942,608
Profit Margin
0.00%
Return On Assets TTM
-22.28%
Return On Equity TTM
-29.62%
Revenue Per Share TTM
0.028
Qtly Revenue Growth YOY
83655.20%
Diluted Eps TTM
-1.08
Qtly Earnings Growth YOY
0.00%
Trailing PE
0.00
Forward PE
0
Price Sales TTM
421.9796
Price Book MRQ
2.3532
Enterprise Value Revenue
2
Enterprise Value EBITDA
0
71.50
4.08%807.73
0.61%293.54
0.59%17.80
0.28%316.55
0.14%453.75
0.11%803.19
0.00%140.28
-0.70%289.09
-0.26%718.43
-0.20%